article thumbnail

Sweetened drinks linked to atrial fibrillation risk

American Heart News - Heart News

Research Highlights: An analysis of health data in the UK Biobank found a 20% higher risk of irregular heart rhythm, known as atrial fibrillation, among people who said they drank two liters or more per week (about 67 ounces) of artificially sweetened.

article thumbnail

Novel drug therapies for atrial fibrillation

Nature Reviews - Cardiology

Nature Reviews Cardiology, Published online: 28 February 2024; doi:10.1038/s41569-024-01004-2 Atrial fibrillation is the most common sustained arrhythmia and imposes a substantial burden on patients and health-care providers.

article thumbnail

Rare and Common Genetic Variation Underlying Atrial Fibrillation Risk

JAMA Cardiology

This genetic association study evaluates the association of genetic variants with atrial fibrillation, cardiomyopathy, and heart failure.

article thumbnail

Dose Reduction of Edoxaban in Older Patients With Atrial Fibrillation

JAMA Cardiology

This post hoc analysis of a randomized clinical trial investigates if patients 80 years and older with atrial fibrillation benefit from lower-dose anticoagulants even in the absence of prespecified dose-reduction criteria.

article thumbnail

Pulsed field ablation procedures found safe and effective for atrial fibrillation patients

Medical Xpress - Cardiology

Pulsed field ablation (PFA) is safe for treating patients with common types of atrial fibrillation (AF), according to the largest study of its kind on this new technology, led by the Icahn School of Medicine at Mount Sinai.

article thumbnail

Artificial intelligence-enabled atrial fibrillation detection using smartwatches: current status and future perspectives

Frontiers in Cardiovascular Medicine

Atrial fibrillation (AF) significantly increases the risk of stroke and heart failure, but is frequently asymptomatic and intermittent; therefore, its timely diagnosis poses challenges. Early detection in selected patients may aid in stroke prevention and mitigate structural heart complications through prompt intervention.

article thumbnail

Study compares rivaroxaban, warfarin with apixaban for cirrhosis, atrial fibrillation

Medical Xpress - Cardiology

For patients with cirrhosis and nonvalvular atrial fibrillation (AF), initiators of rivaroxaban or warfarin versus apixaban have significantly higher rates of major hemorrhage, according to a study published online July 9 in the Annals of Internal Medicine.